Dashti HM, Bo-Abbas YY, Mathew TC, Hussein T, Behbehani A, Khoursheed M, Al-Sayer HM, Al-Zaid NS: Ketogenic diet modifies the risk factors for heart disease in obese subjects. Nutrition 19: 901–902, 2003
Wilder RM: The effect of ketonemia on the course of epilepsy. Mayo Clin Proc 2: 307–308, 1921
Pilkington TRE, Gainsborough H, Rosenoer VM, Carey M: Diet and weight reduction in obese. Lancet 16: 856–858, 1960
Westman EC, Mavropoulos J, Yancy WS, Volek JS: A review of low-carbohydrate ketogenic diets. Curr Atheroscler Rep 5: 476–483, 2003
Volek JS, Sharman MJ, Love DM, Avery NG, Gomez AL, Scheett TP, Kraemer WJ: Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism 51: 864–870, 2002
Volek JS, Gomez AL, Kraemer WJ: Fasting lipoprotein and postprandial triacylglycerol responses to a low-carbohydrate diet supplemented with n-3 fatty acids. J Am Coll Nutr 19: 383–391, 2000
Larosa JC, Fry AG, Muesing R, Rosing DR: Effects of high-protein, low carbohydrate dieting on plasma lipoproteins and body weight. J Am Diet Assoc 77: 264–270, 1980
Dattilo AM, Kris Etherton PM: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56: 320–328, 1992
Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81: 7B–I2B, 1998
Taubes G: Nutrition: the soft science of dietary fat. Science 291: 2536–2545, 2001
Zammit VA, Waterman IJ, Topping D, McKay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131: 2074–2077, 2001
Reaven GM: Diet and syndrome X. Curr Atheroscler Rep 2: 503–507, 2000
Krauss RM: Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 131: 340S–343S, 2001
Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC: A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 140: 769–777, 2004
Westman EC, Mavropoulos J, Yancy WS, Volek JS: A review of low-carbohydrate ketogenic diets. Curr Atheroscler Rep 5: 476–483, 2003
Kwiterovich PO Jr, Vining EP, Pyzik P, Skolasky R Jr, Freeman JM: Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 290: 912–920, 2003
Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gomez AL, Scheett TP, Volek JS: A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 132: 1879–1885, 2002
Lofgren IE, Herron KL, West KL, Zern TL, Patalay M, Koo SI, Fernandez} ML: Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women. J Nutr Biochem 16: 245–250, 2005
Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 142: 403–411, 2005
Ezenwaka CE, Kalloo R: Carbohydrate-induced hypertriglyceridaemia among West Indian diabetic and non-diabetic subjects after ingestion of three local carbohydrate foods. Indian J Med Res 121: 23–31, 2005
Bray GA: The risks and disadvantages of obesity. In: The Obese Patient. Philadelphia: Saunders, 1976, pp. 215–251
Grundy SM, Barnett JP: Metabolic and health complications of obesity. Dis Mon 36: 641–731, 1990
Pi-Sunyer FX: Medical hazards of obesity. Ann Intern Med 119: 655–660, 1993
Simopoulos AP, Van Itallie TB: Body weight, health and longevity. Ann Intern Med 100: 285–295, 1984
Dashti HM, Mathew TC, Hussein T, Asfar SK, Behbehani AI, Al-Sayer HM, Al-Zaid NS: Long term effects of ketogenic diet in obese subjects. Exp Clin Cardiol 9: 200–205, 2004
Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 22(348): 2074–2081, 2003
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 22(348): 2082–2090, 2003
Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA: A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 88: 1617–1623, 2003
Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ, Samaha FF: The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 18(140): 778–785, 2004
Astrup A, Larsen TM, Harper A: Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss? Lancet 364: 897–899, 2004
Zammit VA, Waterman IJ, Topping D, McKay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131: 2074–2077, 2001
Gotto AM: Interrelationship of triglycerides with lipoproteins and High-density lipoproteins. Am J Cardiol 66: 20A–23A, 1990
Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pagoda JM, Labree L, Hemphill LC, Kramsch DM, Blankenhorn DH: Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 90: 42–49, 1994
Hodis HN, Mock WJ: Triglyceride-rich lipoproteins and progression of coronary artery disease. Curr Opin Lipid 6: 209–214, 1995
Bissett JK, Wyeth RP, Matts JP, Johnson JW: Plasma lipid concentrations and subsequent coronary occlusion after a first myocardial infarction. Am J Med Sci 305: 139–144, 1993
Krauss RM, Williams PT, Brensike J, Detre KM, Lindgren FT, Kelsey SF, Vranizan K, Levy RI: Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet 2: 62–66, 1987
Hulley SB, Roseman RH, Bawol RD, Brand RJ: Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1389, 1980
Austin MA: Plasma triglyceride as a risk factor for coronary artery disease: the epidemiologic evidence and beyond. Am J Epidemiol 129: 249–259, 1989
Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213–221, 1996
Gaziano, JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE: Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96: 2520–2525, 1997
Noakes M, Foster P, Keogh J, Clifton P: Very low carbohydrate diets for weight loss and cardiovascular risk. Asia Pac J Clin Nutr 13(Suppl): S64, 2004
NIH Consensus development panel on triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus conference: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269: 505–510, 1993
Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH: A prospective study of cholesterol apolipoproteins and the risk of myocardial infarction. N Engl J Med 325: 373–381, 1991
Harder H, Dinesen B, Astrup A: The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic subjects. Int J Obes Relat Metab Disord 28: 180–182, 2004
Battino M, Ferreiro MS: Ageing and the Mediterranean diet: a review of the role of dietary fats. Public Health Nutr 7: 953–958, 2004
La Vecchia C: Mediterranean diet and cancer. Public Health Nutr 7: 965–968, 2004
Shahtahmasebi S, Shahtahmasebi S: A case follow-up report: possible health benefits of extra virgin olive oil. Scientific World Journal 4: 853–858, 2004
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4